Department of Medical Oncology
Susan Fotheringham has not added Biography.
If you are Susan Fotheringham and would like to personalize this page please email our Author Liaison for assistance.
Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis.
Cancer cell Jan, 2009 | Pubmed ID: 19111881
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.
Proceedings of the National Academy of Sciences of the United States of America Apr, 2010 | Pubmed ID: 20308564
Dana-Farber Cancer Institute
Boston, MA
Susan Fotheringham1,2,
Keren Levanon1,2,3,
Ronny Drapkin1,2,4
1Department of Medical Oncology, Dana-Farber Cancer Institute,
2Harvard Medical School, Boston, MA,
3Sheba Cancer Research Center, Chaim Sheba Medical Center,
4Department of Pathology, Brigham and Women's Hospital
Prywatność
Warunki Korzystania
Zasady
Skontaktuj Się z Nami
Poleć Bibliotece
BIULETYNY JoVE
Badania
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archiwum
Edukacja
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Autorzy
Bibliotekarze
Dostęp
O JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone